Skip to main content
Premium Trial:

Request an Annual Quote

AdvanDx Pockets $15M in Series C Funds; Will Use Cash to Drive S&M, R&D

NEW YORK (GenomeWeb News) — Molecular diagnostics developer AdvanDx will use a $15 million blast of Series C financing from BioMérieux and two existing investors to push sales and marketing efforts and to expand its R&D facilities, the company said yesterday.
Joining BioMérieux in the financing is LD Pensions and Scandinavian Life Science Venture.
AdvanDx makes a suite of diagnostics for detecting, identifying, and managing pathogens and infections, including the PNA FISH and Evigene tests, which detect antibiotic-resistant bacteria.
BioMérieux in May become Advent’s US distributor of tests for identifying Staphylococcus aureus, Candida albicans, and Enterococcus faecalis.
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.